Calcified Tissue International

, Volume 76, Issue 5, pp 336–340 | Cite as

Analysis of Bone Mineral Content in Horizontally HIV-Infected Children Naïve to Antiretroviral Treatment

  • S. Mora
  • I. Zamproni
  • V. Giacomet
  • L. Cafarelli
  • C. Figini
  • A. Viganò


Low bone mass is a frequent finding in HIV-infected individuals. Reduced bone mass has been found in vertically infected children who are receiving antiretroviral treatment. Little is known about bone mass in horizontally infected young patients who are naïve to antiretroviral therapy. We measured the bone mineral content (BMC) at the lumbar spine and in the whole skeleton by using dual-energy X-ray absorptiometry (DXA) in 16 HIV-infected children (age 9.3 ± 3.9 years) naïve to antiretroviral treatment, and in 119 healthy children (age 9.7 ± 3.3 years). Thirteen patients were also pair-matched by anthropometric measures, sex, and age with healthy children. Median spine BMC of HIV-infected children was 14.9 g (8.2–39.2 g), and whole body BMC was 1106.1 g (55.5–2344.1 g). Spine BMC of healthy children was 18.6 g (6.8–52.2 g), and whole body BMC was 1213.5 g (541.0–2722.0 g). Multivariate analysis showed a mean difference of spine BMC values of 0.004 g (P = 0.64) between the two groups. Similarly, the whole body BMC difference between the two groups (0.001 g) was not statistically significant (P = 0.55). Mean spine BMC measurements in the case-control evaluation were 21.1 g (9.7 g) (patients), and 22.3 g (6.9 g) (controls). Whole body BMC measurements of patients and controls were 1258.5 g (539.6 g) and 1311.1 g (479.2 g), respectively. In both cases the differences were not significant. The duration of HIV infection did not relate to BMC values. In conclusion, horizontally HIV-infected children naïve to antiretroviral therapy have bone mineral measurements comparable to those of healthy children.


Bone mass Bone mineral content Children HIV-infection 



The research in this article was supported by Grant No. 054 from Istituto Superiore di Sanità - V Programma Nazionale di Ricerca sull’AIDS - 2004.

Dr. Ilaria Zamproni is the recipient of a fellowship by Fondazione Carlo Erba, Milano, Italy.


  1. 1.
    Serrano, S, Mariñoso, ML, Soriano, JC, Rubiés-Prat, J, Aubia, J, Coll, J, Bosch, J, Rio, L, Vila, J, Goady, A, Nacher, M 1995Bone remodelling in human immunodeficiency virus-1−infected patientsA histomorphometric study. Bone16185191Google Scholar
  2. 2.
    Paton, NIJ, Macallan, DC, Griffin, GE, Pazianas, M 1997Bone mineral density in patients with human immunodeficiency virus infectionCalcif Tissue Int613032CrossRefPubMedGoogle Scholar
  3. 3.
    Tebas, P, Powderly, WG, Claxton, S, Marin, D, Tantisiriwat, W, Teitelbaum, SL, Yarasheski, KE 2000Accelerated bone and mineral loss in HIV-infected patients receiving potent antiretroviral therapyAIDS14F63F67CrossRefPubMedGoogle Scholar
  4. 4.
    Carr, A, Miller, J, Eisman, JA, Cooper, DA 2001Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapyAIDS15703709CrossRefPubMedGoogle Scholar
  5. 5.
    Fairfield, WP, Finkelstein, JS, Klibanski, A, Grinspoon, SK 2001Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndromeJ Clin Endocrinol Metab8620202026CrossRefPubMedGoogle Scholar
  6. 6.
    Moore, AL, Vashisht, A, Sabin, CA, Mocroft, A, Madge, S, Phillips, AN, Studd, JWW, Johnson, MA 2001Reduced bone mineral density in HIV-positive individualsAIDS1517311733CrossRefPubMedGoogle Scholar
  7. 7.
    Gold, J Pocock, N Li, Y Albion St Centre Osteoporosis and HIV Study group2002Bone mineral density abnormalities in patients with HIV infectionJ Acquir Immune Defic Syndr30131132CrossRefPubMedGoogle Scholar
  8. 8.
    Loiseau-Pérès, S, Delaunay, C, Poupon, S, Lespessailles, E, Ballouche, N, Arsac, P, Benhamou, CL 2002Osteopenia in patients infected by the human immunodeficiency virusA case control study. Joint Bone Spine69482485CrossRefGoogle Scholar
  9. 9.
    Teichmann, J, Stephan, E, Discher, T, Lange, U, Fedrelin, K, Stracke, H, Friese, G, Lohmeyer, J, Bretzel, RG 2003Osteopenia in HIV-infected women prior to highly active antiretroviral therapyJ Infect46221227CrossRefPubMedGoogle Scholar
  10. 10.
    O’Brien, KO, Razavi, M, Henderson, RA, Caballero, B, Ellis, KJ 2001Bone mineral content in girls perinatally infected with HIVAm J Clin Nutr73821826PubMedGoogle Scholar
  11. 11.
    Mora, S, Sala, N, Bricalli, D, Zuin, G, Chiumello, G, Viganò, A 2001Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapyAIDS1518231829CrossRefPubMedGoogle Scholar
  12. 12.
    Arpadi, SM, Horlick, M, Thornton, J, Cuff, PA, Wang, J, Kotler, DP 2002Bone mineral content is lower in prepubertal HIV-infected childrenJ Acquir Immune Defic Syndr29450454PubMedGoogle Scholar
  13. 13.
    Mora, S, Zamproni, I, Beccio, S, Bianchi, R, Giacomet, V, Viganò, A 2004Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated HIV-infected childrenJ Clin Endocrinol Metab892428PubMedGoogle Scholar
  14. 14.
    CDC 19921993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adultsMMWR Morb Mortal Wkly Rep4115Google Scholar
  15. 15.
    CDC1994Revised classification system for human immunodeficiency virus infection in children less than 13 years of ageMMWR Morb Mortal Wkly Rep43110Google Scholar
  16. 16.
    Njeh, CF, Samat, SB, Nightingale, A, McNeil, EA, Boivin, CM 1997Radiation dose and in vitro precision in paediatric bone mineral density measurement using dual X-ray absorptiometryBr J Radiol70719727PubMedGoogle Scholar
  17. 17.
    Mora, S, Bachrach, L, Gilsanz (2003) “Noninvasive techniques for bone mass measurement” In: Glorieux, FH, Pettifor, JM, Jüppner, H (eds.), Pediatric bone Biology & diseases, Academic Press, San Diego, pp 303-324Google Scholar
  18. 18.
    Prentice, A, Parsons, TJ, Cole, TJ 1994Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinantsAm J Clin Nutr60837842PubMedGoogle Scholar
  19. 19.
    Stein, E, Shane, E 2003Secondary osteoporosisEndocrinol Metab Clin North Am32115134CrossRefPubMedGoogle Scholar
  20. 20.
    Hantgartner, T 1990Influence of fat on bone measurements with dual-energy absorptiometryBone Miner97178CrossRefPubMedGoogle Scholar
  21. 21.
    Fessel, WJ, Hurley, LB 2003Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone diseaseAIDS17255257CrossRefPubMedGoogle Scholar
  22. 22.
    Viganò, A, Mora, S 2004Adverse effects of antiretroviral therapy: Focus on bone densityExpert Opin Drug Saf3199208PubMedGoogle Scholar
  23. 23.
    Diamond, T, Depczynski, B 1996Acquired osteosclerosis associated with intravenous drug use and hepatitis C infectionBone19679683CrossRefPubMedGoogle Scholar
  24. 24.
    Shaker, JL, Reinus, WR, Whyte, MP 1998Hepatitis C-associated osteosclerosis: late onset after blood transfusion in an elderly womanJ Clin Endocrinol Metab839398CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • S. Mora
    • 1
  • I. Zamproni
    • 1
  • V. Giacomet
    • 2
  • L. Cafarelli
    • 2
  • C. Figini
    • 2
  • A. Viganò
    • 2
  1. 1.Laboratory of Pediatric Endocrinology Scientific Institute H San Raffaele MilanItaly
  2. 2.Chair of PediatricsL. Sacco Hospital MilanItaly

Personalised recommendations